HealthEquity Total Revenue vs Research Development Analysis

HQY Stock

USD 79.21 0.81 1.03%

HealthEquity financial indicator trend analysis is much more than just examining HealthEquity latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether HealthEquity is a good investment. Please check the relationship between HealthEquity Total Revenue and its Research Development accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HealthEquity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index.

For more information on how to buy HealthEquity Stock please use our How to Invest in HealthEquity guide.

Total Revenue vs Research Development

Total Revenue vs Research Development Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of HealthEquity Total Revenue account and Research Development. At this time, the significance of the direction appears to have totally related.

The correlation between HealthEquity's Total Revenue and Research Development is 0.99. Overlapping area represents the amount of variation of Total Revenue that can explain the historical movement of Research Development in the same time period over historical financial statements of HealthEquity, assuming nothing else is changed. The correlation between historical values of HealthEquity's Total Revenue and Research Development is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Revenue of HealthEquity are associated (or correlated) with its Research Development. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Research Development has no effect on the direction of Total Revenue i.e., HealthEquity's Total Revenue and Research Development go up and down completely randomly.

Correlation Coefficient

0.99

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Total Revenue

Total revenue comprises all receipts HealthEquity generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Research Development

Most indicators from HealthEquity's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into HealthEquity current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HealthEquity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index.

For more information on how to buy HealthEquity Stock please use our How to Invest in HealthEquity guide.At this time, HealthEquity's Selling General Administrative is fairly stable compared to the past year. Tax Provision is likely to rise to about 20.3 M in 2024, whereas Sales General And Administrative To Revenue is likely to drop 0.08 in 2024.

	2021	2022	2023	2024 (projected)
Gross Profit	423.7M	490.1M	529.9M	556.4M
Total Revenue	756.6M	861.7M	999.6M	1.0B

Gross Profit Total Revenue

HealthEquity fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Accounts Payable	Cash	Other Assets	Good Will	Common Stock Shares Outstanding	Short Term Investments	Inventory	Other Current Assets	Total Liab	Intangible Assets	Common Stock	Property Plant Equipment	Property Plant And Equipment Net	Net Debt	Retained Earnings	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Non Current Liabilities Total	Other Stockholder Equity
Total Assets		0.91	0.89	0.98	0.97	0.67	0.69	0.61	0.99	0.76	0.91	-0.76	0.95	0.91	0.93	0.76	0.92	0.85	0.84	0.83	1.0	0.67	0.94	0.75	0.92	0.97
Other Current Liab	0.91		0.99	0.85	0.95	0.61	0.72	0.76	0.88	0.74	0.85	-0.75	0.92	0.98	0.97	0.77	0.91	0.96	0.9	0.9	0.92	0.68	0.94	0.77	0.97	0.84
Total Current Liabilities	0.89	0.99		0.81	0.94	0.55	0.66	0.78	0.85	0.7	0.82	-0.72	0.9	0.97	0.94	0.72	0.9	0.98	0.92	0.87	0.89	0.62	0.9	0.72	0.96	0.79
Total Stockholder Equity	0.98	0.85	0.81		0.9	0.72	0.72	0.54	0.98	0.77	0.9	-0.73	0.91	0.83	0.89	0.77	0.91	0.74	0.73	0.8	0.97	0.71	0.93	0.76	0.83	1.0
Other Liab	0.97	0.95	0.94	0.9		0.57	0.62	0.63	0.95	0.68	0.87	-0.74	0.96	0.96	0.93	0.7	0.9	0.94	0.92	0.84	0.97	0.59	0.9	0.7	0.96	0.88
Accounts Payable	0.67	0.61	0.55	0.72	0.57		0.43	0.61	0.66	0.59	0.57	-0.48	0.5	0.6	0.74	0.55	0.59	0.48	0.55	0.51	0.69	0.4	0.72	0.56	0.6	0.73
Cash	0.69	0.72	0.66	0.72	0.62	0.43		0.49	0.64	0.77	0.84	-0.65	0.68	0.62	0.65	0.87	0.69	0.58	0.41	0.9	0.64	0.99	0.76	0.87	0.61	0.7
Other Assets	0.61	0.76	0.78	0.54	0.63	0.61	0.49		0.53	0.58	0.62	-0.6	0.51	0.74	0.77	0.57	0.58	0.77	0.71	0.69	0.62	0.44	0.69	0.57	0.72	0.53
Good Will	0.99	0.88	0.85	0.98	0.95	0.66	0.64	0.53		0.72	0.88	-0.74	0.94	0.89	0.91	0.71	0.91	0.81	0.83	0.78	0.99	0.61	0.92	0.7	0.9	0.97
Common Stock Shares Outstanding	0.76	0.74	0.7	0.77	0.68	0.59	0.77	0.58	0.72		0.75	-0.56	0.68	0.7	0.76	0.87	0.7	0.64	0.57	0.78	0.73	0.78	0.81	0.87	0.7	0.76
Short Term Investments	0.91	0.85	0.82	0.9	0.87	0.57	0.84	0.62	0.88	0.75		-0.84	0.87	0.82	0.83	0.78	0.83	0.78	0.69	0.93	0.89	0.82	0.87	0.77	0.82	0.88
Inventory	-0.76	-0.75	-0.72	-0.73	-0.74	-0.48	-0.65	-0.6	-0.74	-0.56	-0.84		-0.74	-0.72	-0.72	-0.44	-0.7	-0.69	-0.63	-0.81	-0.75	-0.6	-0.73	-0.44	-0.72	-0.72
Other Current Assets	0.95	0.92	0.9	0.91	0.96	0.5	0.68	0.51	0.94	0.68	0.87	-0.74		0.88	0.86	0.69	0.97	0.86	0.8	0.81	0.94	0.66	0.87	0.68	0.88	0.9
Total Liab	0.91	0.98	0.97	0.83	0.96	0.6	0.62	0.74	0.89	0.7	0.82	-0.72	0.88		0.97	0.71	0.84	0.96	0.97	0.85	0.92	0.58	0.93	0.71	1.0	0.81
Intangible Assets	0.93	0.97	0.94	0.89	0.93	0.74	0.65	0.77	0.91	0.76	0.83	-0.72	0.86	0.97		0.75	0.87	0.91	0.92	0.84	0.95	0.61	0.98	0.75	0.97	0.88
Common Stock	0.76	0.77	0.72	0.77	0.7	0.55	0.87	0.57	0.71	0.87	0.78	-0.44	0.69	0.71	0.75		0.71	0.67	0.56	0.84	0.73	0.89	0.82	1.0	0.71	0.76
Property Plant Equipment	0.92	0.91	0.9	0.91	0.9	0.59	0.69	0.58	0.91	0.7	0.83	-0.7	0.97	0.84	0.87	0.71		0.83	0.75	0.78	0.91	0.66	0.86	0.7	0.84	0.9
Property Plant And Equipment Net	0.85	0.96	0.98	0.74	0.94	0.48	0.58	0.77	0.81	0.64	0.78	-0.69	0.86	0.96	0.91	0.67	0.83		0.94	0.84	0.86	0.54	0.84	0.67	0.96	0.72
Net Debt	0.84	0.9	0.92	0.73	0.92	0.55	0.41	0.71	0.83	0.57	0.69	-0.63	0.8	0.97	0.92	0.56	0.75	0.94		0.7	0.87	0.36	0.84	0.56	0.97	0.72
Retained Earnings	0.83	0.9	0.87	0.8	0.84	0.51	0.9	0.69	0.78	0.78	0.93	-0.81	0.81	0.85	0.84	0.84	0.78	0.84	0.7		0.81	0.88	0.87	0.84	0.84	0.77
Non Current Assets Total	1.0	0.92	0.89	0.97	0.97	0.69	0.64	0.62	0.99	0.73	0.89	-0.75	0.94	0.92	0.95	0.73	0.91	0.86	0.87	0.81		0.61	0.94	0.72	0.93	0.96
Cash And Short Term Investments	0.67	0.68	0.62	0.71	0.59	0.4	0.99	0.44	0.61	0.78	0.82	-0.6	0.66	0.58	0.61	0.89	0.66	0.54	0.36	0.88	0.61		0.73	0.89	0.57	0.68
Net Receivables	0.94	0.94	0.9	0.93	0.9	0.72	0.76	0.69	0.92	0.81	0.87	-0.73	0.87	0.93	0.98	0.82	0.86	0.84	0.84	0.87	0.94	0.73		0.82	0.94	0.92
Common Stock Total Equity	0.75	0.77	0.72	0.76	0.7	0.56	0.87	0.57	0.7	0.87	0.77	-0.44	0.68	0.71	0.75	1.0	0.7	0.67	0.56	0.84	0.72	0.89	0.82		0.71	0.75
Non Current Liabilities Total	0.92	0.97	0.96	0.83	0.96	0.6	0.61	0.72	0.9	0.7	0.82	-0.72	0.88	1.0	0.97	0.71	0.84	0.96	0.97	0.84	0.93	0.57	0.94	0.71		0.82
Other Stockholder Equity	0.97	0.84	0.79	1.0	0.88	0.73	0.7	0.53	0.97	0.76	0.88	-0.72	0.9	0.81	0.88	0.76	0.9	0.72	0.72	0.77	0.96	0.68	0.92	0.75	0.82

Click cells to compare fundamentals

HealthEquity Account Relationship Matchups

HealthEquity fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	2.6B	2.7B	3.1B	3.1B	3.2B	3.4B
Other Current Liab	96.7M	126.2M	104.7M	89.5M	95.6M	54.8M
Total Current Liabilities	152.1M	204.3M	153.2M	131.1M	117.1M	79.0M
Total Stockholder Equity	1.0B	1.4B	1.9B	1.9B	2.0B	2.1B
Other Liab	133.1M	128.5M	114.0M	95.4M	109.7M	115.2M
Accounts Payable	4.0M	1.6M	27.5M	13.9M	12.0M	6.9M
Cash	191.7M	328.8M	225.4M	254.3M	404.0M	212.6M
Other Assets	35.1M	37.4M	49.8M	52.2M	1.0	0.95
Good Will	1.3B	1.3B	1.6B	1.6B	1.9B	2.0B
Common Stock Shares Outstanding	68.5M	75.7M	83.1M	84.4M	87.0M	68.4M
Other Current Assets	33.8M	58.6M	38.5M	31.8M	48.6M	51.0M
Total Liab	1.5B	1.3B	1.3B	1.2B	1.2B	609.8M
Intangible Assets	783.3M	767.0M	973.1M	936.4M	835.9M	428.2M
Property Plant Equipment	33.5M	118.6M	87.0M	69.3M	79.7M	83.7M
Property Plant And Equipment Net	116.7M	118.6M	87.0M	69.3M	54.4M	47.5M
Net Debt	1.1B	746.2M	782.8M	740.2M	529.2M	299.8M
Retained Earnings	211.5M	220.3M	176.1M	149.9M	205.6M	121.8M
Non Current Assets Total	2.3B	2.2B	2.8B	2.7B	2.7B	2.8B
Cash And Short Term Investments	191.7M	328.8M	225.4M	254.3M	404.0M	243.5M
Net Receivables	70.5M	72.8M	87.4M	96.8M	104.9M	52.6M
Liabilities And Stockholders Equity	2.6B	2.7B	3.1B	3.1B	3.2B	1.6B
Non Current Liabilities Total	1.4B	1.1B	1.1B	1.1B	1.1B	578.7M
Other Stockholder Equity	818.8M	1.2B	1.7B	1.7B	1.8B	1.9B
Property Plant And Equipment Gross	116.7M	118.6M	87.0M	69.3M	95.4M	51.6M
Total Current Assets	296.0M	460.2M	351.3M	382.9M	557.4M	320.0M
Net Tangible Assets	(1.1B)	(715.1M)	(766.4M)	(688.9M)	(620.0M)	(589.0M)
Non Currrent Assets Other	35.1M	37.4M	49.8M	52.2M	(768.1M)	(729.7M)
Retained Earnings Total Equity	85.3M	171.9M	211.5M	220.3M	253.4M	266.1M
Capital Surpluse	261.2M	305.2M	818.8M	1.2B	1.3B	1.4B
Non Current Liabilities Other	1.4B	8.8M	14.2M	12.7M	19.3M	18.3M
Net Invested Capital	2.3B	2.4B	2.8B	2.8B	2.9B	2.2B
Net Working Capital	145.4M	255.5M	198.2M	251.8M	440.3M	298.8M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

S	SentinelOne
GOOG	Alphabet Inc Class C
C	Citigroup

When determining whether HealthEquity offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of HealthEquity's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Healthequity Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Healthequity Stock:

How To Invest In HealthEquity

Details

Is HealthEquity Stock a good investment?

Details

What is HealthEquity's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in HealthEquity. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in producer price index.

For more information on how to buy HealthEquity Stock please use our How to Invest in HealthEquity guide.

You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for HealthEquity Stock analysis

When running HealthEquity's price analysis, check to measure HealthEquity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HealthEquity is operating at the current time. Most of HealthEquity's value examination focuses on studying past and present price action to predict the probability of HealthEquity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HealthEquity's price. Additionally, you may evaluate how the addition of HealthEquity to your portfolios can decrease your overall portfolio volatility.

	Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated
	Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios
	Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum
	Technical Analysis Check basic technical indicators and analysis based on most latest market data
	Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market.
	Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites

Is HealthEquity's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of HealthEquity. If investors know HealthEquity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about HealthEquity listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.96)

Earnings Share

0.64

Revenue Per Share

11.682

Quarterly Revenue Growth

0.122

Return On Assets

0.0256

The market value of HealthEquity is measured differently than its book value, which is the value of HealthEquity that is recorded on the company's balance sheet. Investors also form their own opinion of HealthEquity's value that differs from its market value or its book value, called intrinsic value, which is HealthEquity's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because HealthEquity's market value can be influenced by many factors that don't directly affect HealthEquity's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between HealthEquity's value and its price as these two are different measures arrived at by different means. Investors typically determine if HealthEquity is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, HealthEquity's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

HealthEquity Total Revenue vs Research Development Analysis

Total Revenue vs Research Development

Total Revenue vs Research Development Correlation Analysis

Correlation Coefficient

Total Revenue

Research Development

HealthEquity fundamental ratios Correlations

HealthEquity Account Relationship Matchups

High Positive Relationship

High Negative Relationship

HealthEquity fundamental ratios Accounts

Also Currently Popular

Complementary Tools for HealthEquity Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Total Assets
Other Stockholder Equity	+ 1.0	Total Stockholder Equity
Non Current Liabilities Total	+ 1.0	Total Liab
Common Stock Total Equity	+ 1.0	Common Stock
Good Will	+ 0.99	Total Assets
Total Current Liabilities	+ 0.99	Other Current Liab

Inventory	- 0.84	Short Term Investments
Retained Earnings	- 0.81	Inventory
Inventory	- 0.76	Total Assets
Non Current Assets Total	- 0.75	Inventory
Inventory	- 0.75	Other Current Liab
Other Current Assets	- 0.74	Inventory